US BANCORP \DE\ - KIORA PHARMACEUTICALS INC ownership

KIORA PHARMACEUTICALS INC's ticker is and the CUSIP is 49721T309. A total of 14 filers reported holding KIORA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of KIORA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$38
-11.6%
670.0%0.00%
Q2 2023$43
-80.8%
670.0%0.00%
Q1 2023$224
-2.6%
670.0%0.00%
Q4 2022$230670.0%0.00%
Q3 2022$0670.00%
Other shareholders
KIORA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ALBION FINANCIAL GROUP /UT 6$210.00%
UBS Group AG 166$5550.00%
NewEdge Advisors, LLC 200$6680.00%
OSAIC HOLDINGS, INC. 36$1200.00%
DIMENSIONAL FUND ADVISORS LP 12,254$40,9280.00%
US BANCORP \DE\ 67$2240.00%
WELLS FARGO & COMPANY/MN 11$370.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 8$270.00%
ACADIAN ASSET MANAGEMENT LLC 21,460$700.00%
View complete list of KIORA PHARMACEUTICALS INC shareholders